Entero Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE: GridAI CEO Sawyer Discloses 7.1% Stake
GridAI Technologies Corp. CEO Jason David Sawyer has reported beneficial ownership of 540,000 shares, representing 7.1% of the company's common stock, acquired through restricted stock units.
Arif Nasir Ali and affiliated entities have filed an amended Schedule 13D, indicating a reduction in their beneficial ownership of Entero Therapeutics, Inc. common stock to below the 5% reporting threshold following a recent share sale.
Arif Nasir Ali and affiliated entities have disclosed a combined beneficial ownership of approximately 5.26% of Entero Therapeutics, Inc.'s common stock, acquired for investment purposes.